Webinar discusses drug repurposing strategies in clinical pharmacology, highlighting therapeutic insights and methodologies.
Join us for webinar from Prof. Ahmed El-Yazbi, Professor of Pharmacology and Therapeutics at Alamein International University, and Adjunct Professor of Chemistry and Biochemistry at Texas Tech University on the repurposing of drugs in clinical pharmacology. Prof. El-Yazbi graduated in 2001 from the Faculty of Pharmacy in Alexandria University, with a BPharm degree. He received his PhD in Pharmacology from the Faculty of Medicine at the University of Alberta in 2008. He was then awarded two fellowships from the Canadian Institutes for Health Research and Alberta Innovates-Health Solutions to conduct a research program studying the regulation of cerebral blood flow at the Hotchkiss Brain Institute at the University of Calgary. Dr. El-Yazbi has two board certifications in Clinical Pharmacy and Pharmacotherapy from Canadian and American Boards. Dr. El-Yazbi leads a large research group in Egypt and collaborates with multiple research partners nationally and internationally. His research uses multiple tools ranging from molecular studies to machine learning to focus on cardiometabolic pathophysiology, producing over 100 research articles and mentoring 25 post-graduate students. His translational research program investigates the mechanisms of cardiovascular dysfunction in metabolic disease and identifies targets for novel therapies.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: